Health · Medical Research · 7 hrs ago
New HIV drug approved in Japan and US as treatment options expand
Islatravir was approved in Japan and the US in spring 2026 as a new treatment for HIV.
Its development was led by Hiroaki Mitsuya and others at a Japanese medical research institute.
Mitsuya has worked on HIV research since the 1980s and is a leading developer of new medicines.
He says HIV treatment has changed dramatically over the past decade, with more options now available.
Earlier treatments were often incomplete, according to Mitsuya.
The approval adds another medicine to the choices for people with HIV.
The story does not say what happens next for the drug.
Islatravir, a new HIV treatment, was approved in Japan and the United States in spring 2026.
Its development was led by Hiroaki Mitsuya and others at the National Institute of Global Health and Medicine.
Mitsuya said HIV treatment has changed dramatically over the past decade.
He has been involved in HIV research since the 1980s.
- Who
- Islatravir was developed under the leadership of Hiroaki Mitsuya and others.
- What
- The new HIV treatment was approved in Japan and the United States.
- When
- Spring 2026.
- Where
- Japan and the United States.
- Why
- Not stated.
This story does not have two clearly opposing sides.
Hiroaki Mitsuya has been involved in HIV research.
Islatravir was approved in Japan and the United States.
- Drug
- Islatravir
- Approval
- Japan and the United States
- Approval date
- Spring 2026
- Development lead
- Hiroaki Mitsuya and others at the National Institute of Global Health and Medicine
1 source
What people are saying
HIV treatment has dramatically evolved over the past 10 years.